US3854041A - Process for detection of biological activity - Google Patents
Process for detection of biological activity Download PDFInfo
- Publication number
- US3854041A US3854041A US00421354A US42135473A US3854041A US 3854041 A US3854041 A US 3854041A US 00421354 A US00421354 A US 00421354A US 42135473 A US42135473 A US 42135473A US 3854041 A US3854041 A US 3854041A
- Authority
- US
- United States
- Prior art keywords
- blood
- medium
- compound
- sucrose
- percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000004071 biological effect Effects 0.000 title claims abstract description 13
- 238000000034 method Methods 0.000 title claims description 33
- 230000008569 process Effects 0.000 title claims description 27
- 238000001514 detection method Methods 0.000 title description 13
- 239000008280 blood Substances 0.000 claims abstract description 39
- 210000004369 blood Anatomy 0.000 claims abstract description 39
- 239000002609 medium Substances 0.000 claims abstract description 28
- 229930006000 Sucrose Natural products 0.000 claims abstract description 25
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 25
- 239000005720 sucrose Substances 0.000 claims abstract description 25
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000001963 growth medium Substances 0.000 claims abstract description 13
- 108010008488 Glycylglycine Proteins 0.000 claims abstract description 12
- 229940043257 glycylglycine Drugs 0.000 claims abstract description 12
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims abstract description 10
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims abstract description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 9
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims abstract description 9
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 9
- 230000006872 improvement Effects 0.000 claims abstract description 6
- 150000001875 compounds Chemical class 0.000 claims description 14
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 10
- 239000007789 gas Substances 0.000 claims description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 5
- 239000001569 carbon dioxide Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 238000005259 measurement Methods 0.000 claims description 4
- 238000000855 fermentation Methods 0.000 claims description 3
- 230000004151 fermentation Effects 0.000 claims description 3
- 230000002503 metabolic effect Effects 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 5
- 238000011534 incubation Methods 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 18
- 229920002307 Dextran Polymers 0.000 description 12
- 239000011780 sodium chloride Substances 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000000654 additive Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 239000001974 tryptic soy broth Substances 0.000 description 6
- 108010050327 trypticase-soy broth Proteins 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 238000009640 blood culture Methods 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000031729 Bacteremia Diseases 0.000 description 2
- 241000589539 Brevundimonas diminuta Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 description 2
- 229940025294 hemin Drugs 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000003760 magnetic stirring Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 239000011652 vitamin K3 Substances 0.000 description 2
- 235000012711 vitamin K3 Nutrition 0.000 description 2
- 229940041603 vitamin k 3 Drugs 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 101100264195 Caenorhabditis elegans app-1 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010564 aerobic fermentation Methods 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 239000007330 chocolate agar Substances 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000014670 detection of bacterium Effects 0.000 description 1
- WQZGKKKJIJFFOK-UKLRSMCWSA-N dextrose-2-13c Chemical compound OC[C@H]1OC(O)[13C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-UKLRSMCWSA-N 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 150000002826 nitrites Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- -1 or the like Chemical compound 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/16—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor using radioactive material
Definitions
- a growth medium containing at least about 5 percent by weight of a material selected from the group consisting of sucrose, raffinose and glycylglycine is employed in order to reduce the incidence of high background readings due to sterile blood.
- This invention is directed to an improved means for the detection of biological activity in blood.
- Biological activity in blood such as bacteremia (bacteria in blood)
- bacteremia bacteria in blood
- Culturing was done manually and, of course, was a tedious procedure that required considerable periods of time until the physical presence of bacteria, fungi, or other microorganisms could be detected.
- a general background reading of about five units is frequently encountered. It has also been generally observed when the gas from a sample inoculated with blood is tested, the background reading is generally increased by to units. In other words, even when the blood sample is from a patient who has no microbial infection, the radioactivity will read, on the average, between about 15 and units.
- the gas from the blood sample of a patient with bacteremia or the like provides an even higher reading.
- a reading of about units or more is used as an indication of microorganisms in the blood sample. On occasion the blood background reading can exceed 30 units making it very difficult to distinguish a true positive caused by microbial infection from the background reading.
- Reference to units, herein, is to units of the Bactec instrument. One hundred units are equal to 0.025 microcuries of C activity.
- This invention is directed to the process of detecting biological activity in the blood wherein:
- a growth medium including a C containing carbon source which is fermentable to produce carbon dioxide is inoculated with a blood sample;
- the inoculated sample is exposed to conditions conducive to the occurrence of normal metabolic processes for a period of time sufficient to cause production of carbon dioxide by the fermenting of said source;
- the improvement comprises employing a growth medium containing at least about 5 percent by weight of a material selected from the group consisting of sucrose, raffinose and glycylglycine, whereby the high background readings for the measurement of gaseous C 0 are reduced.
- the process employs a nutrient medium that contains water, a suitable C containing carbon source, a nitrogen source, minerals and trace elements.
- Typical C containing carbon sources may be glucose, fructose, galactose, mannose, rhamnose, or the like, phenylalanine, lysine, arginine or the like, glycerol, urea, or carboxylic acids such as citric acid or the like.
- Glucose which is readily available, constitutes a preferred C containing material.
- the levels of radioactivity will vary from about 0.1 to about 10 microcuries per 10 ml.
- the assimilable nitrogen source may be either organic or inorganic, such as nitrates, nitrites, ammonia, urea, amino acids, or the like, while minerals such as the chlorides, sulfates or phosphates of calcium, sodium, potassium, magnesium or the like and trace elements such as manganese, iron, zinc, cobalt or the like, may also be employed. Vitamins, cofactors or other enrichment agents such as anti-coagulants may also be added if desired.
- the medium may also include a buffer for pH adjustment and maintenance.
- the atmosphere above the culture medium can be air, oxygen, or the like if aerobic tests are being conducted, whereas nitrogen, CO or the like can be employed if anaerobic tests are being conducted.
- Vials containing media for aerobic cultures, designated No. 6A, and vials containing media for anaerobic cultures, designated No. 7A, are commercially available from Johnston Laboratories, Inc.
- a medium suitable for aerobic fermentation (6A) may contain tryptic soy broth, hemin, menadione, sodiumpolyanethol sulfonate, and C -labelled substrates
- a medium suitable for anaerobic culture (7A) may contain tryptic soy broth, yeast extract, hemin, menadione, L-cysteine, sodium polyanethol sulfonate and C-labelled substrates.
- the 50 ml vials containing 30 ml of medium have a radioactivity of about 1.5 microcuries.
- Commercial media have a pH of about 7.3.
- the sample of blood will be added to the medium in amounts ranging from about 0.5 to about 10 percent by volume and the inoculated medium can be cultured under agitation at temperatures between about 20C and about 60C and most often between about 33 and about 39C.
- the length of time for the culture will depend, inter alia, on the amount of inoculum employed and the particular microorganism involved. Tests have demonstrated that microorganisms generally will create a positive response in time periods ranging from 1 to 24 hours.
- the gaseous atmosphere over the culture medium is tested for radioactivity. Readings of about 30 units or more generally have indicated the presence of microbial activity in the blood.
- the threshold reading will, of course, depend in part on the background reading due to the general surroundings. Such noise can readily be determined by testing the atmosphere from a medium that has not been inoculated.
- the reading used to indicate the presence of microorganisms may, of course, vary somewhat depending on the level of general background noise. When the threshold level has been reached, the sample is considered positive. Negative samples are further incubated and tested again to insure against the presence of slow growing microbes.
- a material selected from the group consisting of sucrose, raffinose, and glycylglycine is incorporated in the medium in amounts of at least about 5 percent by weight and preferably at least about 10 percent by weight. Amounts of 30 percent by weight or more may be employed.
- Sucrose is a particularly preferred additive of this invention. Because the additives of this invention particularly reduce the high background readings due to sterile blood, the threshold reading to indicate the presence of microbes may be reduced to about 20 or about 25.
- EXAMPLES l7 Stock culture bacteria were grown overnight on chocolate agar slants at 35C. The organisms tested were Diplococcus pneumoniae, I-Iaemophilus sp., Pseudomonas aeruginosa, Pseudomonas diminuta, and Streptococcus pyogenes. The growth on the slants was suspended with 1 ml tryptic soy broth, diluted with tryptic soy broth to 1110,000 of the original concentration, and 1 ml of each suspension inoculated into the test media. For the Haemophilus culture, 1 ml of whole blood was also added to the culture media. The control medium was a 50 ml JLI No.
- Example 1 1 ml of whole blood obtained from a healthy donor was used instead of bacteria. These blood cultures were tested as described above except on a 4-hour cycle.
- the Growth Index (G1) is an arbitrary scale of 0 to which is linearly proportional to the amount of C detected. A full-scale reading of 100 corresponds to 0.025 microcurie of C liberated. The maximum G1 indicated in the data is the highest GI produced by a culture after its detection.
- Table 1 provides some chemical characteristics of the agents and the resultant media, assuming 100 percent dissociation of NaCl.
- Control 107 sucrose 103 0 0 Table 2 reflects the effect of each of the agents on Th whole blood from a healthy patient. As this table dem- 15 f GI for 103 Control Samples onstrates, only the addition of 10% sucrose affected the was Wh'le the f mfixlmum GI for the P maximum Growth Index cent sucrose-containing med1um was 13.5. The median max1mum GI for the 85 control samples in the O-2O category was while the median maximum G1 for the TABLE 2 20 same 85 samples in 10 percent sucrose-containing medium was 13.5.
- a growth medium including a C containing carlow. bon source which is fermentablc to produce carbon
- TABLE 6 Ex Medium pH Appearance l0 Control, tryptic soy broth with 0.025% sodium 7.2 clear solution T polyanethol sulfonate and the C-l4 sub stratesl.5 microcuiies per 30 cc, 50 cc vial.
- TABLE 7 dioxide is inoculated with a blood sample
- the inoculated sample is exposed to conditions conducive to the occurrence of normal metabolic processes for a period of time sufficient to cause production of carbon dioxide by the fermenting of said source;
- said fermentation is measured for radioactivity to determine the presence of C 0 the improvement comprising incorporating into the medium at least about 5 percent by weight of a compound selected from the group consisting of sucrose, raftinose and glycylglycine whereby the background noise for the measurement of radioactivity of gaseous C 0 is reduced.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
A sample of blood to be tested for the presence of biological activity is added to a suitable growth medium which includes C14 containing carbon source fermentable to produce gaseous C14O2. After a suitable incubation period, a portion of the gaseous atmosphere above the medium is analyzed for the presence of radioactivity. In the improvement herein described, a growth medium containing at least about 5 percent by weight of a material selected from the group consisting of sucrose, raffinose and glycylglycine is employed in order to reduce the incidence of high background readings due to sterile blood.
Description
Unite States Patent 1 91 Waters et a1.
[451 Dec. 10, 1974 A. Zwarun, 7 Dell Ct., Baltimore, Md. 21207 22 Filedz Dec. 3, 1973 21 App1.N0.:421,354
Related US. Application Data [63] Continuation-in-part of Ser. No. 353,952, April 24,
[52] 11.8. C1 250/303, 250/380, 424/1, [51] Int. Cl. ..G0lt1/00, Cl2k H10 [58] Field of Search 424/1; 195/127 [56] References Cited UNITED STATES PATENTS 3,506,402 4/1970 Simon 250/380 Axen et al. 424/1 Waters 250/380 Primary Examiner-Harold A. Dixon 5 7 ABSTRACT A sample of blood to be tested for the presence of biological activity is added to a suitable growth medium which includes C containing carbon source fermentable to produce gaseous C 0 After a suitable incubation period, a portion of the gaseous atmosphere above the medium is analyzed for the presence of radioactivity. In the improvement herein described, a growth medium containing at least about 5 percent by weight of a material selected from the group consisting of sucrose, raffinose and glycylglycine is employed in order to reduce the incidence of high background readings due to sterile blood.
8 Claims, No Drawings PROCESS FOR DETECTION OF BIOLOGICAL ACTIVITY RELATED APPLICATIONS This application is a continuation-in-part of application Ser. No. 353,952 filed Apr. 24, 1973 and entitled Process for Detection of Biological Activity.
DESCRIPTION OF THE INVENTION This invention is directed to an improved means for the detection of biological activity in blood.
Biological activity in blood, such as bacteremia (bacteria in blood), in the past, presented a difficult detection problem. Culturing was done manually and, of course, was a tedious procedure that required considerable periods of time until the physical presence of bacteria, fungi, or other microorganisms could be detected.
More recently, a radiometric technique for the detection of biological activity in the blood has undergone clinical testing and has been adopted for commercial practice. ln that method samples of blood are inoculated into a suitable growth medium that includes a C containing carbon source, the inoculated medium is incubated for a suitable period, and a portion of the gaseous atmosphere is analyzed for while in the gaseous state. Such process is described, inter alia, in U.S. Pat. No. 3,676,679 issued July 11, 1972; and in the articles Early Detection of Bacterial Growth, with Carbon Labeled Glucose," Radiology, 92, No. 1, pp. l545 (Jan. 1969); Automated Radiometric Detection of Bacterial Growth in Blood Cultures," J. Labs. Clin. Med., 75, No. 3, pp. 529-34 (March 1970); and Automated Radiometric Detection of Bacteria in 2,967 Blood Cultures, Applied Microbiology, 22, No. 5, pp. 846-849 (Nov. 1971). A commercialinstrument for the practice of a rapid, automated process is available under the trademark Bactec (Johnston Laboratories, Inc.).
In practicing the process for the gaseous detection of the C O a general background reading of about five units is frequently encountered. It has also been generally observed when the gas from a sample inoculated with blood is tested, the background reading is generally increased by to units. In other words, even when the blood sample is from a patient who has no microbial infection, the radioactivity will read, on the average, between about 15 and units. The gas from the blood sample of a patient with bacteremia or the like, of course, provides an even higher reading. Generally, a reading of about units or more is used as an indication of microorganisms in the blood sample. On occasion the blood background reading can exceed 30 units making it very difficult to distinguish a true positive caused by microbial infection from the background reading.
Reference to units, herein, is to units of the Bactec instrument. One hundred units are equal to 0.025 microcuries of C activity.
While the described system has proven effective for the rapid detection of biological activity in the blood and is in commercial use, it is desirable to reduce the background readings due to blood and particularly to reduce the incidence of high background readings produced by sterile blood.
It is an object of this invention to reduce the incidence of high background readings due to sterile blood.
It is another object of this invention to reduce the background reading in the gas measurement of the C 0 when blood is screened for the presence of biological activity.
This invention is directed to the process of detecting biological activity in the blood wherein:
a. a growth medium including a C containing carbon source which is fermentable to produce carbon dioxide is inoculated with a blood sample;
b. the inoculated sample is exposed to conditions conducive to the occurrence of normal metabolic processes for a period of time sufficient to cause production of carbon dioxide by the fermenting of said source; and
c. at least a portion of the gaseous atmosphere from said fermentation is measured for radioactivity to determine the presence of C 0 The improvement, according to the present invention, comprises employing a growth medium containing at least about 5 percent by weight of a material selected from the group consisting of sucrose, raffinose and glycylglycine, whereby the high background readings for the measurement of gaseous C 0 are reduced.
The precise reason for the increased background reading due to components in the blood is not fully understood. Whatever the cause, it has been discovered that the background reading is decreased if the growth medium contains at least about 5 percent of the additives of this invention. The mechanism by which such additives decrease the background reading is not clear. While the additives of this invention increase osmotic pressure, other agents which also increase osmotic pressure, such as dextran, lactose, sodium chloride, or potassium chloride, do not materially reduce the background reading caused by blood.
In tests employing this invention, the background reading due to the blood has generally been decreased somewhat; Importantly, however, anomalously high readings due to sterile blood may be eliminated so that such samples produce only normal readings. Therefore the accuracy of the technique is increased.
The process to which this invention relates and the apparatus for carrying out the process are described, inter alia, in US. Pat. No. 3,676,679; Radiology, 92, No. 1, pp. 154-5 (Jan 1969); J. Labs. Clin. Med, 75, No. 3, pp. 529-34 (March 1970); Applied Microbiology, 22, No. 5, pp. 846-849 (Nov. 1971); Johnston Laboratories, Inc. Technical Data Application Notes JLI512,JL1604,JLI609A,JL1610A,JLI6l1,and JLI 612. These publications are incorporated herein by reference.
Generally, the process employs a nutrient medium that contains water, a suitable C containing carbon source, a nitrogen source, minerals and trace elements. Typical C containing carbon sources may be glucose, fructose, galactose, mannose, rhamnose, or the like, phenylalanine, lysine, arginine or the like, glycerol, urea, or carboxylic acids such as citric acid or the like. Glucose, which is readily available, constitutes a preferred C containing material. Generally the levels of radioactivity will vary from about 0.1 to about 10 microcuries per 10 ml. The assimilable nitrogen source may be either organic or inorganic, such as nitrates, nitrites, ammonia, urea, amino acids, or the like, while minerals such as the chlorides, sulfates or phosphates of calcium, sodium, potassium, magnesium or the like and trace elements such as manganese, iron, zinc, cobalt or the like, may also be employed. Vitamins, cofactors or other enrichment agents such as anti-coagulants may also be added if desired. Finally, the medium may also include a buffer for pH adjustment and maintenance. The atmosphere above the culture medium can be air, oxygen, or the like if aerobic tests are being conducted, whereas nitrogen, CO or the like can be employed if anaerobic tests are being conducted.
Commercial media (except for the additive of this invention) are described in detail in the above publications and particularly in JLI 61 1, and JLI 612. A broad selection of possible components that may be included in the media is also set out in US. Pat. No. 3,676,679. While that patent indicates that up to 20 percent or more carbohydrate may be employed in the medium, preferred media are said to contain only up to about 0.001 percent carbohydrate and commercial media do contain such small amounts of carbohydrate added as such. In addition, if the media contains peptone, yeast extract, or the like, an additional 1 percent or so of carbohydrates may be present as a component of this additive.
Vials containing media for aerobic cultures, designated No. 6A, and vials containing media for anaerobic cultures, designated No. 7A, are commercially available from Johnston Laboratories, Inc. A medium suitable for aerobic fermentation (6A) may contain tryptic soy broth, hemin, menadione, sodiumpolyanethol sulfonate, and C -labelled substrates, while a medium suitable for anaerobic culture (7A) may contain tryptic soy broth, yeast extract, hemin, menadione, L-cysteine, sodium polyanethol sulfonate and C-labelled substrates. The 50 ml vials containing 30 ml of medium have a radioactivity of about 1.5 microcuries. Commercial media have a pH of about 7.3.
Most frequently the sample of blood will be added to the medium in amounts ranging from about 0.5 to about 10 percent by volume and the inoculated medium can be cultured under agitation at temperatures between about 20C and about 60C and most often between about 33 and about 39C. The length of time for the culture will depend, inter alia, on the amount of inoculum employed and the particular microorganism involved. Tests have demonstrated that microorganisms generally will create a positive response in time periods ranging from 1 to 24 hours.
After a suitable period of time, e.g., 8 hours, the gaseous atmosphere over the culture medium is tested for radioactivity. Readings of about 30 units or more generally have indicated the presence of microbial activity in the blood. The threshold reading will, of course, depend in part on the background reading due to the general surroundings. Such noise can readily be determined by testing the atmosphere from a medium that has not been inoculated. The reading used to indicate the presence of microorganisms may, of course, vary somewhat depending on the level of general background noise. When the threshold level has been reached, the sample is considered positive. Negative samples are further incubated and tested again to insure against the presence of slow growing microbes.
In accordance with the improvement of this invention, a material selected from the group consisting of sucrose, raffinose, and glycylglycine is incorporated in the medium in amounts of at least about 5 percent by weight and preferably at least about 10 percent by weight. Amounts of 30 percent by weight or more may be employed. Sucrose is a particularly preferred additive of this invention. Because the additives of this invention particularly reduce the high background readings due to sterile blood, the threshold reading to indicate the presence of microbes may be reduced to about 20 or about 25.
The following examples are included in order to illustrate the practice of this invention. These examples are included for illustrative purposes only and in no way are intended to limit the scope of the invention.
EXAMPLES l7 Stock culture bacteria were grown overnight on chocolate agar slants at 35C. The organisms tested were Diplococcus pneumoniae, I-Iaemophilus sp., Pseudomonas aeruginosa, Pseudomonas diminuta, and Streptococcus pyogenes. The growth on the slants was suspended with 1 ml tryptic soy broth, diluted with tryptic soy broth to 1110,000 of the original concentration, and 1 ml of each suspension inoculated into the test media. For the Haemophilus culture, 1 ml of whole blood was also added to the culture media. The control medium was a 50 ml JLI No. 6A blood culture vial (Johnston Laboratories, Cockeysville, Maryland) containing 30 ml of enriched tryptic soy broth with 1.5 microcuries of C -labeled substrates and a magnetic stirring bar. The hypertonic media consisted of various agents added to the control medium. These agents were either 1% NaCl, 3% NaCl, 10% sucrose, 5% dextran (Sigma Chemical Company, St. Louis, Mo., approximate average molecular weight 15,000 20,000), 10% dextran, or 15% dextran. All percentages are expressed on a weight to volume basis.
The evolution of C 0 by these cultures was monitored by using the automated BACTEC Model 225 system (Johnston Laboratories). This radiometric technique has been demonstrated to be very sensitive in detecting C 0 production by all levels of bacterial inocula and is used in clinical laboratories for routine blood culturing. The culture vials were incubated at 35C while providing continuous agitation through the magnetic stirring bar. Samples were analyzed for C 0 production every 2 hours using air 10% CO as the flushing and culture gas.
In Example 1, 1 ml of whole blood obtained from a healthy donor was used instead of bacteria. These blood cultures were tested as described above except on a 4-hour cycle.
Detection time of the cultures was taken when the Growth Index reached a value of 20 or higher. The Growth Index (G1) is an arbitrary scale of 0 to which is linearly proportional to the amount of C detected. A full-scale reading of 100 corresponds to 0.025 microcurie of C liberated. The maximum G1 indicated in the data is the highest GI produced by a culture after its detection.
Table 1 provides some chemical characteristics of the agents and the resultant media, assuming 100 percent dissociation of NaCl.
TABLE 1 the sample was inoculated into a vial having 30 ml of JLl 6A medium containing 10 percent sucrose. The moles particles} pH of maximum Growth Index values for 103 clinical tests Ex Agent Aw/v Molurity liter medium are mponcd i T b 4 g 1 Control 7.4 2 NaCl 1 0.17 0.34 7.35 3 NaCl 3 0.51 1.02 7.3 TABLE 4 4 sucrose 10 0.29 0.29 7.3 5 dextran 5 0.0025 0.0025 7.25 Max. Max. Max. 6 dextran 10 0.005 0.005 7.15 G1 G] G] 7 dextran 15 0.0075 0.0075 7.05 10 -20 21-30 31 or more Control 85 15 3 Control 107: sucrose 103 0 0 Table 2 reflects the effect of each of the agents on Th whole blood from a healthy patient. As this table dem- 15 f GI for 103 Control Samples onstrates, only the addition of 10% sucrose affected the was Wh'le the f mfixlmum GI for the P maximum Growth Index cent sucrose-containing med1um was 13.5. The median max1mum GI for the 85 control samples in the O-2O category was while the median maximum G1 for the TABLE 2 20 same 85 samples in 10 percent sucrose-containing medium was 13.5.
Ex Medium Max. C11 EXAMPLE 9 C 7 The procedure of Examples 1-7 was repeated except 1 ontrol 2 comm 10% sucrose 8 that hemm and menadtone were omitted from the me 3 C0mml+1% ct 15 dium and 3 ml of sterile blood was used as tnoculum. 4 Control+-3% NaCl 15 The results (mean of 3 replicates) of the control, the. 5 Control+-5% dextran 20 Comr l t 1 6 Control+10%dextran 20 O q percent sucrose, and 116 C01!- 7 Control+ 15% deman 22 trol containing 10 percent glycylglycine are shown in Table 5 below.
TABLE 5 Medium 1 2 3 4 (days) Control 17 18 16 15 Table 3 represents the effects of the varlous agents Control 10% sucrose 13 t0 9 8 on the tes bacteria Control 10% glycylglycine l7 l4 9 6 TABLE 3 D. neumoniae P. aeruginosa P. diminuta Haemophilgs S. gygggngs detecdetecdetecdetecdetection tion tion tion tion k g k time max. time max. time rriax. time max. time max. Ex (hrs) G1 (hrs) G1 (hrs) GI (hrs) G1 (hrs.) G1
1 Control 6 93 2 I00 14 49 6 100 4 32 2 Control+ 1% NaCl 8 76 2 100 18 40 10 4 34 3 Control +3% NaCl NG 4 I00 PG NG 6 37 4 Control+10% sucrose 10 55 4 [00 a 18 39 12 33 12 5 Control 5% dextran 8 4 100 16 45 6 66 6 37 6 Control+ 10% dextran 8 I00 4 100 18 40 6 61 6 28 7 I0 100 4 100 18 44 6 67 8 28 Control 15% dextran NG, no growth; PG, poor growth; good growth, no detection EXAMPLE 8 A 6 ml sample of blood was drawn from a patient and 6 3 ml of the sample was inoculated into a vial containing 30 ml of .lLl 6A medium while the remaining 3 ml of EXAMPLES 10-16 about l.5 microcuries per 30 cc of medium. ln these examples. 50 cc vials containing 30 cc of the control medium were employed. The chemical and physical characteristics of the media are shown in Table 6 be- We claim: l. [n the process of detecting biological activity in blood wherein:
a. a growth medium including a C containing carlow. bon source which is fermentablc to produce carbon TABLE 6 Ex Medium pH Appearance l0 Control, tryptic soy broth with 0.025% sodium 7.2 clear solution T polyanethol sulfonate and the C-l4 sub stratesl.5 microcuiies per 30 cc, 50 cc vial. l l Control+ 10% D Raffinose 7.2 clear solution 12 Control 10% sucrose 7.2 clear solution 13 Control 10% D Galactose 6.0 very dark solution 14 Control l0% Glycl-L-asparagine 6.4 dark suspension 15 Control+ l0% D Cellobiose 6.5 dark solution 16 Control+ 10% Lactose 6.6 dark solution Three cc of sterile whole blood were inoculated m each of the media above. The vials were tested for CO periodically using a mixture of 90 percent air and 10 percent CO as the flushing gas at C. The vials in these examples, as in the earlier examples, were maintained at 35C. Replicates were run. The average maximal reading obtained is shown in Table 7 below.
TABLE 7 dioxide is inoculated with a blood sample;
b. the inoculated sample is exposed to conditions conducive to the occurrence of normal metabolic processes for a period of time sufficient to cause production of carbon dioxide by the fermenting of said source; and
c. at least a portion of the gaseous atmosphere from Average Maximal Gl Obtained Average Max. Gl
As the readings (CI) reported in Table 7 d emonstrate, both sucrose and raffinose reduced the background noise.
EXAMPLE 17 TABLE 8 Sucrose Gl ll ll l0 pH 7.2 pH 6.8 pH 6.6
Since modification of this invention will be apparent to those skilled in the art, it is intended that this invention be limited only by the scope of the appended claims.
said fermentation is measured for radioactivity to determine the presence of C 0 the improvement comprising incorporating into the medium at least about 5 percent by weight of a compound selected from the group consisting of sucrose, raftinose and glycylglycine whereby the background noise for the measurement of radioactivity of gaseous C 0 is reduced.
2. The process of claim 1 wherein the compund is present in the medium in amounts of at least about 10 percent by weight;
3. The process of claim 1 wherein the compound is sucrose;
4. The process of claim 2 wherein the compound sucrose;
5. The process of claim 1 wherein the compound raffmose;
6. The process of claim 2 wherein the compound raffinose;
7. The process of claim 1 wherein the compound glycylglycine;
8. The process of claim 2 wherein the compound glycylglycine.
Claims (8)
1. IN THE PROCESS OF DETCTING BIOLOGICAL ACTIVITY IN BLOOD WHEREIN: A. A GROWTH MEDIUM INCLUDING A C14 CONTAINING CARBON SOURCE WHICH IS FERMENTABLE TO PRODUCE CARBON DIOXIDE IS INOCULATED WITH A BLOOD SAMPLE; B. THE INOCULATED SAMPLE IS EXPOSED TO CONDITIONS CONDUCIVE TO THE OCCURRENCE OF NORMAL METABOLIC PROCESSES FOR A PERIOD OF TIME SUFFICIENT TO CAUSE PRODUCTION OF CARBON DIOXIDE BY THE FERMENTAING OF SAID SOURCE; AND C. AT LEAST A PORTION OF THE GASEOUS ATMOSPHERE FROM SAID FERMENTATION IS MEASURED FOR RADIOACTIVITY TO DETERMINED THE PRESENCE OF C14O2, THE IMPROVEMENT COMPRISING INCORPORATING INTO THE MEDIUM AT LEAST ABOUT 5 PERCENT BY WEIGHT OF A COMPOUND SELECTED FROM THE GROUP CONSISTING OF SUCROSE, RAFFINOSE AND GLYCYLGLYCINE WHEREBY THE BACGROUND NOISE FOR THE MEASUREMENT OF RADIOCATIVITY OF GASES C14O2 IS REDUCED.
2. The process of claim 1 wherein the compund is present in the medium in amounts of at least about 10 percent by weight;
3. The process of claim 1 wherein the compound is sucrose;
4. The process of claim 2 wherein the compound is sucrose;
5. The process of claim 1 wherein the compound is raffinose;
6. The process of claim 2 wherein the compound is raffinose;
7. The process of claim 1 wherein the compound is glycylglycine;
8. The process of claim 2 wherein the compound is glycylglycine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US00421354A US3854041A (en) | 1973-04-24 | 1973-12-03 | Process for detection of biological activity |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35395273A | 1973-04-24 | 1973-04-24 | |
US00421354A US3854041A (en) | 1973-04-24 | 1973-12-03 | Process for detection of biological activity |
Publications (1)
Publication Number | Publication Date |
---|---|
US3854041A true US3854041A (en) | 1974-12-10 |
Family
ID=26998165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US00421354A Expired - Lifetime US3854041A (en) | 1973-04-24 | 1973-12-03 | Process for detection of biological activity |
Country Status (1)
Country | Link |
---|---|
US (1) | US3854041A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4908321A (en) * | 1989-02-03 | 1990-03-13 | Varma Shambhu D | Radio-active method for determining trace amounts of peroxide |
US4994378A (en) * | 1989-09-08 | 1991-02-19 | Becton, Dickinson And Company | Method for reducing blood carbon dioxide background in bacterial media by the addition of micelles of saponin and a phospholipid |
US20210024877A1 (en) * | 2018-04-03 | 2021-01-28 | Momentum Bioscience Limited | Microorganism separation and detection |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3506402A (en) * | 1964-06-12 | 1970-04-14 | Helmut F Simon | Method and device for measuring the radioactivity of 14c- and/or 3h-marked compounds |
US3555143A (en) * | 1966-06-02 | 1971-01-12 | Pharmacia Ab | Method for the determination of proteins and polypeptides |
US3676679A (en) * | 1970-04-22 | 1972-07-11 | Johnston Lab Inc | Apparatus for detecting biological activity |
-
1973
- 1973-12-03 US US00421354A patent/US3854041A/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3506402A (en) * | 1964-06-12 | 1970-04-14 | Helmut F Simon | Method and device for measuring the radioactivity of 14c- and/or 3h-marked compounds |
US3555143A (en) * | 1966-06-02 | 1971-01-12 | Pharmacia Ab | Method for the determination of proteins and polypeptides |
US3676679A (en) * | 1970-04-22 | 1972-07-11 | Johnston Lab Inc | Apparatus for detecting biological activity |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4908321A (en) * | 1989-02-03 | 1990-03-13 | Varma Shambhu D | Radio-active method for determining trace amounts of peroxide |
US4994378A (en) * | 1989-09-08 | 1991-02-19 | Becton, Dickinson And Company | Method for reducing blood carbon dioxide background in bacterial media by the addition of micelles of saponin and a phospholipid |
US20210024877A1 (en) * | 2018-04-03 | 2021-01-28 | Momentum Bioscience Limited | Microorganism separation and detection |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Trimble et al. | Bacteriology of manganese nodules: III. Reduction of MnO2 by two strains of nodule bacteria | |
Engel et al. | Growth and autotrophic metabolism of Nitrosomonas europaea | |
US4152213A (en) | Vacuum detection of bacteria | |
Silverman et al. | Studies on the chemoautotrophic iron bacterium Ferrobacillus ferrooxidans: I. An improved medium and a harvesting procedure for securing high cell yields | |
Pecher et al. | On the redox control of synthesis of anaerobically induced enzymes in enterobacteriaceae | |
Valera et al. | Nutrition and physiology of denitrifying bacteria | |
Uffen | Metabolism of carbon monoxide by Rhodopseudomonas gelatinosa: cell growth and properties of the oxidation system | |
Burggraaf et al. | Estimates of Frankia growth under various pH and temperature regimes | |
Abdel Wahab | Nitrogen fixation by Bacillus strains isolated from the rhizosphere of Ammophila arenaria | |
Collins et al. | Proton movements coupled to lactate and alanine transport in Escherichia coli: isolation of mutants with altered stoichiometry in alanine transport | |
Palmquist et al. | Enzymatic techniques for the study of pathways of carbohydrate utilization in the rumen | |
US3854041A (en) | Process for detection of biological activity | |
US4390631A (en) | Process for producing bacteria having high nitrilase activity | |
US4073694A (en) | Microbiological assay of aminoglycoside antibiotics | |
Medrek et al. | Comparative incidence of coliform bacteria and enterococci in undisturbed soil | |
JPH1142083A (en) | 5-Aminolevulinic acid-producing microorganism and method for producing 5-aminolevulinic acid using the same | |
US3858045A (en) | Detection of biological activity | |
CA1106785A (en) | Hypertonic culture media | |
Fuchs et al. | The availability of sulphur for Clostridium perfringens and an examination of hydrogen sulphide production | |
Grobler et al. | Bacterial electrode for L-arginine | |
Kempner et al. | Effect of CO2 on the growth rate of the pneumococcus | |
WENG et al. | Headspace gas composition and chitin content as measures of Rhizopus stolonifer growth | |
Gadkari et al. | Influence of nitrogen source on growth and nitrogenase activity in Azotobacter vinelandii | |
Williams | The growth of Lancefield group D streptococci in the presence of sodium fluoride | |
US4769332A (en) | Method and composition for enhancement of growth of mycobacteria |